Study: Vaporized, Low-Potency Cannabis Mitigates Neuropathic Pain

  • by Paul Armentano, NORML Deputy Director January 3, 2013

    The administration of vaporized, low THC cannabis is associated with reduced pain in subjects with neuropathy, according to clinical trial data published online by The Journal of Pain.

    Investigators at the University of California, Davis Medical Center conducted a double-blind, placebo-controlled, crossover study evaluating the analgesic efficacy of vaporized cannabis in 39 subjects, the majority of whom were experiencing neuropathic pain despite traditional treatment. Subjects inhaled cannabis of either moderate THC (3.53 percent), low dose THC (1.29 percent), or zero THC (placebo). Subjects continued to take all other concurrent medications as per their normal routine during the 3- to 4-week study period. Spontaneous pain relief, the primary outcome variable, was assessed by asking participants to indicate the intensity of their current pain on a 100-mm visual analog scale (VAS) between 0 (no pain) and 100 (worst possible pain).

    Researchers reported: “Both the low and medium doses proved to be salutary analgesics for the heterogeneous collection of neuropathic pain conditions studied. Both active study medications provided statistically significant 30% reductions in pain intensity when compared to placebo.”

    They concluded: “Both the 1.29% and 3.53% vaporized THC study medications produced equal antinociception at every time point. … [T]he use of low doses could potentially be prescribed by physicians interested in helping patients use cannabis effectively while minimizing cognitive and psychological side effects. Viewed with this in mind, the present study adds to a growing body of literature supporting the use of cannabis for the treatment of neuropathic pain. It provides additional evidence of the efficacy of vaporized cannabis as well as establishes low-dose cannabis (1.29%) as having a favorable risk-benefit ratio.”

    Previous clinical trials have indicated that inhaled cannabis can safety and effectively relieve various types of pain, particularly neuropathy — a hard-to-treat nerve condition often associated with cancer, HIV, spinal cord injury, diabetes, multiple sclerosis, and other conditions. These include the following double-blind, placebo-controlled (FDA gold-standard) studies:

    Ware et al. 2010. Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. CMAJ 182: 694-701.

    Wilsey et al. 2008. A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain. Journal of Pain 9: 506-521.

    Ellis et al. 2008. Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial. Neuropsychopharmacology 34: 672-80.

    Abrams et al. 2007. Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial. Neurology 68: 515-521.

    Wallace et al. 2007. Dose-dependent Effects of Smoked Cannabis on Capsaicin-induced Pain and Hyperalgesia in Healthy Volunteers Anesthesiology 107: 785-796.

    Separate clinical trial data also reports that inhaled “cannabis augments the analgesic effect of opioids” and therefore “may allow for opioid treatment at lower doses with fewer side effects.”

    Since 1999, US sales of opiate drugs have tripled in number and in 2010, a record-setting 254 million prescriptions for opioids were filled in the United States — enough to medicate every American adult around the clock for a month. (In particular, the manufacturing of the drug Oxycodone has increased from 8.3 tons in 1997 to 105 tons in 2011, an increase of 1,200 percent.) Overdose deaths from the use of prescription painkillers are also now at record levels, totaling some 15,000 annually — more than triple the total a decade ago.

    Full text of the study, “Low-dose vaporized cannabis significantly improves neuropathic pain,” appears in The Journal of Pain.

    48 responses to “Study: Vaporized, Low-Potency Cannabis Mitigates Neuropathic Pain”

    1. jmalmo says:

      Unfortunately, my mother, who suffers terribly from post-herpetic neuropathic pain, will not use cannabis because of the stigma associated with its use. Legalize it!

    2. RUT says:

      Sounds like more factual proof that cannabis is not a class 1 substance. You get the feeling our government is playing stupid so they can keep laws as they are. All while they weigh what way the political winds are blowing on this issue. How can you trust a government that is so blind to truth and fairness. It is really a shame that these so called leaders can not stop this giant police machine that they have created from incriminating our young people. Most of the 850,000 arrested last year for mere possession of a harmless plant. I guess we can all hope they are starting to get the message in Washington D.C.. WE MUST THANK THE POLITICIANS OF BOTH PARTIES WHO WILL STAND UP FOR THIS ISSUE! LET RESEARCH CONTINUE TO PROVE THIS PLANTS VALUE.

    3. John McClane says:

      we need to break that stigma jmalmo. 80% of Americans support medical and we’re still treated like criminals!

    4. Galileo Galilei says:

      I would like to see if it helps my carpal tunnel pain, but the pain is at its worst in the morning, and I will NOT get stoned that early. The whole day, is shot and when you want to play guitar later the enhanced hearing is not there.

    5. fishcreekbob says:

      Yes it does stop and reduce 8-10 level 24/7 Gates of Hell Pain. All by itself.

    6. […] Study: Vaporized, Low-Potency Cannabis Mitigates Neuropathic Pain […]

    7. carrie says:

      I have had phn for 3 1/2 years and without cannabis, would not be able to live my daily life as full BC there are no other effective treatments for PHN and other neuropathies. It is the difference between existing and living. Without mmj creams, teas, and other meds my own physical therapist wouldn’t be able to help. Keep the research coming!

    8. Charles says:

      It’s a shame that congress keeps sweeping the medical cannabis issue under the rug. All that does is prevent suffering patients from being able to have a little better quality of life. It’s very clear that the majority of Americans want to help patients with cancer and debilitating diseases, but lawmakers continue to avoid helping them by failing to legalize medical cannabis. It’s truly unbelievable that they continue to fail to pass a compassionate care law! Shame on them!

    9. Mac says:

      Well that explains why I love to vape mids in the AM to help with anxiety/depression/anorexia!!